Document is current
Any future updates will be listed below
-
Authors
Bartsch, Rupert
Dormann, Clemens
Egle, Daniel
Gampenrieder, Simon P.
Pristauz-Telsnigg, Gunda
Rinnerthaler, Gabriel
Singer, Christian F.
Gnant, Michael https://orcid.org/0000-0003-1002-2118
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 9 February 2026
Accepted: 20 February 2026
First Online: 18 March 2026
Conflict of interest
: R. Bartsch: honoraria: Agendia, Amgen, Astra-Zeneca, BMS, Daiichi-Sankyo, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, MedMedia, Novartis, Pfizer, Pierre-Fabre, Roche, Stemline; research support: Astra-Zeneca, Daiichi-Sanyko, MSD; Travel Support: Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Gilead, MSD, Novartis, Pfizer, Roche. C. Dormann: honoraria: Agendia, Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Gilead, MSD, MedMedia, Novartis, Pfizer, Roche, Stemline; travel support: Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Gilead, MSD, Novartis, Roche, Ipsen, Stemline. D. Egle: honoraria: Agendia, Amgen, Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Gilead, MSD, Menarini/Stemline, Novartis, Pfizer, Roche, Sirius Medical; research support: Sirius Medical, Schär Nutrition; travel support: Daiichi-Sankyo, Menarini/Stemline. S.P. Gampenrieder: honoraria: Novartis, Roche, BMS, AstraZeneca, MSD, Pfizer, Lilly, Seagen, Daiichi Sankyo, Janssen, Gilead, Roche, Astellas, Stemline Therapeutics, Bayer, Agendia; travel support: Roche, Amgen, Novartis, Pfizer, Bayer, Celgene, Daiichi Sankyo, Janssen, Gilead; research support: Roche, Daiichi Sankyo, Novartis, Pfizer, Caris Life Sciences, Lilly, Seagen, Gilead, AstraZeneca, Stemline Therapeutics. G. Pristauz-Telsnigg: travel support: Amgen, Astra Zeneca, Bondimed, Lilly, Novartis, Pfm Medical, Pfizer, Roche, Sandoz; honoraria: Amgen, Astra Zeneca, Lilly, Novartis, Pfm Medical, Pfizer, Roche, Seagen, Gilead; advisory boards: Astra Zeneca, Novartis, Lilly, Gilead. G. Rinnerthaler: honoraria: AstraZeneca, BMS, Daiichi Sankyo, Eli Lilly, Gilead, MSD, Novartis, Seagen, Stemline; consulting or advisory role: Agendia, AstraZeneca, Eli Lilly, Gilead, Novartis, Pfizer, Stemline; research funding (institution): AstraZeneca, Daiichi Sankyo, Stemline; travel support: Daiichi Sankyo, Gilead, Roche, Servier. C.F. Singer: honoraria: Agendia, Amgen, Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Gilead, MSD, Menarini/Stemline, Novartis, Pfizer, Roche, Sirius Medical; research support: Amgen, Daiichi-Sankyo, AZ, Stemline; travel support: Daiichi-Sankyo, Stemline, Novartis, Astra-Zeneca. M. Gnant: honoraria, travel support: Amgen, AstraZeneca, Bayer, DaiichiSankyo, EliLilly, EPG Health (IQVIA), Menarini-Stemline, MSD, Novartis, PierreFabre, Veracyte; leadership roles at ABCSG GmbH and ABCSG Research Services GmbH.
